| The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2 S Muralidar, SV Ambi, S Sekaran, UM Krishnan Biochimie 179, 85-100, 2020 | 346 | 2020 |
| Role of tau protein in Alzheimer's disease: The prime pathological player S Muralidar, SV Ambi, S Sekaran, D Thirumalai, B Palaniappan International journal of biological macromolecules 163, 1599-1617, 2020 | 156 | 2020 |
| Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19 S Muralidar, G Gopal, S Visaga Ambi Journal of Medical Virology 93 (9), 5260-5276, 2021 | 31 | 2021 |
| Inflammation in myocardial injury-stem cells as potential immunomodulators for myocardial regeneration and restoration S Vadivel, P Vincent, S Sekaran, SV Ambi, S Muralidar, V Selvaraj, ... Life sciences 250, 117582, 2020 | 18 | 2020 |
| The concept of Big Four: Road map from snakebite epidemiology to antivenom efficacy G Gopal, S Muralidar, D Prakash, A Kamalakkannan, ST Indhuprakash, ... International journal of biological macromolecules, 124771, 2023 | 4 | 2023 |
| Microbiome in Acute Respiratory Distress Syndrome (ARDS) G Gopal, S Muralidar, A Kamalakkannan, SV Ambi Microbiome in Inflammatory Lung Diseases, 117-134, 2022 | 3 | 2022 |
| Synbiotics in Lung Cancer D Prakash, SK Venkataramanan, G Gopal, S Muralidar, SV Ambi Synbiotics for the Management of Cancer, 191-204, 2023 | 2 | 2023 |
| Synergistic Potential of Antigen-Specific Vaccines and Immunomodulatory Agents for Lung Cancer Treatment SK Venkataramanan, NS Raman, K Rangasamy, SG Ganapathy, ... Immunotherapy Against Lung Cancer: Emerging Opportunities and Challenges …, 2024 | | 2024 |
| Evolution of Lung Cancer Treatment from Classical Chemotherapy to Advanced Immunotherapy S Maheshkumar, D Prakash, A Subramanian, GD Muthukumarasamy, ... Immunotherapy Against Lung Cancer: Emerging Opportunities and Challenges, 25-43, 2024 | | 2024 |
| Molecular basis of COVID-19, ARDS and COVID-19-associated ARDS: Diagnosis pathogenesis and therapeutic strategies PT Sriramamoorthi, G Gopal, S Muralidar, SR Eswaran, ... Biocell 47 (11), 2335-2350, 2023 | | 2023 |
| Phospholipases in inflammation, gene expression, and apoptosis P Padmanabhan, D Prakash, S Muralidar, A Kamalakkannan, G Gopal, ... Phospholipases in Physiology and Pathology, 3-21, 2023 | | 2023 |
| Microbiome in Asthma-COPD Overlap (ACO) S Muralidar, G Gopal, SV Ambi Microbiome in Inflammatory Lung Diseases, 103-116, 2022 | | 2022 |
| ROS-Mediated Inflammatory Response in Cancer S Muralidar, G Gopal, SV Ambi Handbook of Oxidative Stress in Cancer: Mechanistic Aspects, 1-20, 2021 | | 2021 |
| Targeting Molecular and Cellular Mechanism of Influenza A Virus G Gopal, S Muralidar, SV Ambi Targeting Cellular Signalling Pathways in Lung Diseases, 447-469, 2021 | | 2021 |
Senthil Visaga AmbiSASTRA DEEMED TO BE UNIVERSITYVerified email at scbt.sastra.edu
